Design and Rationale of the COLT Study
A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 940 participants.
Also called NCT07432529
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 940 participants
- Sponsor
- Azienda Sanitaria Locale ASL 6, Livorno
- Registry
-
NCT07432529
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07432529. Randomized; quadruple masking; primary purpose prevention. Start 2026-06-01 (anticipated); primary completion 2027-06-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Design and Rationale of the COLT Study
- Acronym
- COLT
- Condition
- Venous Thrombosis Deep (Limbs)
- Condition
- Post-thrombotic Syndrome
- Condition
- Venous Thromboembolism (VTE)
- Condition
- Venous Insufficiency
- Intervention (Drug)
- Colchicine 0.5 MG Oral Tablet
- Intervention (Drug)
- Placebo
- Lead sponsor
- Azienda Sanitaria Locale ASL 6, Livorno
Record details
- Record id
cardio:ct-nct07432529- Content hash
c114249751eb4e50ccfdba65ec37de239f545a353051dade927b746f4a6c7d73